Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Ophthalmology Physician in Fort Worth, TX
NPI: 1154306777Primary Employer
Texas Retina Associates
texasretina.com
HQ Phone
Get M.D. Patrick's Phone NumberMobile
Get M.D. Patrick's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
2005 - 2027
American Board of Ophthalmology
Ophthalmology
Texas Tech University Health Sciences Center School of Medicine
ttuhsc.edu
Medical School
Until 2001
University of Texas Southwestern Medical Center
Residency • Ophthalmology
2002 - 2005
St. Joseph Medical Center
Internship • Transitional Year
2001 - 2002
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92134Diagnostic imaging of retina | 890 | 2,643 |
| 2 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 702 | 1,219 |
| 3 | 92012Eye and medical examination for diagnosis and treatment, established patient | 361 | 739 |
| 4 | 67028Injection of drug into eye | 329 | 1,429 |
| 5 | J0178Injection, aflibercept, 1 mg | 214 | 2,002 |
The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab.
Authors: Philip Storey, Eric Chen, Edward Wood, Ashkan Abbey, Pooja Pendri, Priya Vakharia, Maitri Mehta
Journal: Am J Ophthalmol
Publication Date: 2018-12-13
Macular atrophy in birdshot retinochoroidopathy: an optical coherence tomography and multifocal electroretinography analysis.
Authors: Birch, D.G., Williams, P.D., Callanan, D., Wang, R., Locke, K.G., Hood, D.C.
A prospective pilot study comparing combined intravitreal ranibizumab and half-fluence photodynamic therapy with ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration.
Authors: David Callanan, Dante Pieramici, Robert Avery, Wayne Solley
Publication Date: 2012-09
Lead Sponsor: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Intravitreal Aflibercept Injection (IAI), DRUG: REGN910-3